Financial markets

ROSEN, GLOBAL INVESTOR COUNSEL, Reminds The GEO Group, Inc. Investors of Important Deadline in Securities Class Action – GEO

Saturday, July 11, 2020 - 10:45pm

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of The GEO Group, Inc. (NYSE: GEO) between February 27, 2020 and June 16, 2020, inclusive (the Class Period), of the important September 8, 2020 lead plaintiff deadline in the securities class action.

Key Points: 
  • Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of The GEO Group, Inc. (NYSE: GEO) between February 27, 2020 and June 16, 2020, inclusive (the Class Period), of the important September 8, 2020 lead plaintiff deadline in the securities class action.
  • To join the GEO class action, go to http://www.rosenlegal.com/cases-register-1894.html or call Phillip Kim, Esq.
  • Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ENPH, FSCT, PRA, WFC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Saturday, July 11, 2020 - 3:50am

If you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline.

Key Points: 
  • If you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline.
  • KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nations premier boutique securities litigation law firms.
  • KSF serves a variety of clients including public institutional investors, hedge funds, money managers and retail investors in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies.
  • KSF has offices in New York, California and Louisiana.

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ELAN, R INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Saturday, July 11, 2020 - 3:50am

If you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline.

Key Points: 
  • If you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline.
  • KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nations premier boutique securities litigation law firms.
  • KSF serves a variety of clients including public institutional investors, hedge funds, money managers and retail investors in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies.
  • KSF has offices in New York, California and Louisiana.

The West Campaign Continues To Wait For A Response From the Republican Party of Texas In Regards to Vote Integrity

Friday, July 10, 2020 - 11:09pm

This law firm represents Colonel West with respect to matters involving his candidacy for Texas Republican State Party Chairman.The author of the letter is Clyde M. Siebman.

Key Points: 
  • This law firm represents Colonel West with respect to matters involving his candidacy for Texas Republican State Party Chairman.The author of the letter is Clyde M. Siebman.
  • "Not having received any response to the enclosed email, I can only conclude that the Republican Party of Texas ("RPT") is not interested in amicably addressing Colonel West's concerns.
  • The reckless way in which the RPT is proceeding with respect to the 2020 State Convention seems calculated to disenfranchise duly elected delegates.
  • Learn more about Allen West, his campaign, and how to keep Texas red by visiting www.west4texas.com .

ESMA updates its Q&As on MiFID II and MiFIR transparency (July 2020)

Saturday, July 11, 2020 - 12:06am

The European Securities and Markets Authority (ESMA), the EUs securities markets regulator, updated today its Q&As regarding transparency issues under the Markets in Financial Instruments Directive (MiFID II) and Regulation (MiFIR).

Key Points: 
  • The European Securities and Markets Authority (ESMA), the EUs securities markets regulator, updated today its Q&As regarding transparency issues under the Markets in Financial Instruments Directive (MiFID II) and Regulation (MiFIR).
  • The new Q&A document provides technical clarifications for the performance of the mandatory systematic internaliser (SI) test.
  • The purpose of this Q&A is to promote a common supervisory approach and practices in the EU on the application of MiFID II and MiFIR, in particular in the performance of the mandatory SI test.
  • ESMA will continue to develop Q&As in the coming months and will review and update them where required.

ESMA updates its opinion on ancillary activity calculations

Saturday, July 11, 2020 - 12:04am

10 July 2020

Key Points: 
  • 10 July 2020

    MiFID - Secondary Markets

    The European Securities and Markets Authority (ESMA), the EUs securities markets regulator, published today an updated Opinion on ancillary activity calculations.

  • The opinion provides the estimation of the market size of commodity derivatives and emission allowances for 2019.
  • ESMA has prepared these estimations based on data reported to the ESMA FITRS system as well as data reported to trade repositories under EMIR.
  • In issuing this opinion, ESMA considers that the guidance on market size will contribute positively to the consistency of supervisory practices and will ensure a uniform approach throughout the Union.

DraftKings Announces Voluntary Delisting of Warrants

Saturday, July 11, 2020 - 12:02am

DraftKings issued public and private placement warrants under the Warrant Agreement that were previously listed on Nasdaq under the ticker symbol DKNGW.

Key Points: 
  • DraftKings issued public and private placement warrants under the Warrant Agreement that were previously listed on Nasdaq under the ticker symbol DKNGW.
  • In light of the small number of holders of the private placement warrants and their limited trading volume following the redemption of the public warrants, and the costs of maintaining the listing, DraftKings has determined voluntarily to delist the private placement warrants.
  • DraftKings has not made arrangements for the listing and/or registration of the private placement warrants on another national securities exchange or quotation medium.
  • The continued listing of DraftKings Class A common stock (including such shares underlying the private placement warrants), which trades on Nasdaq under the ticker symbol DKNG, is not affected by the delisting of the warrants.

COVID-19 Impact & Recovery Analysis- Spirulina Chocolates Market (2020-2024) | The Health Benefits Associated With Spirulina Products to Boost Growth | Technavio

Friday, July 10, 2020 - 11:00pm

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43154

Key Points: 
  • To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43154
    Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources.
  • Our spirulina chocolates market report covers the following areas:
    This study identifies government support in promoting the production of spirulina as one of the prime reasons driving the spirulina chocolates market growth during the next few years.
  • Backed with competitive intelligence and benchmarking, our research reports on the spirulina chocolates market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
  • Register for a free trial today and gain instant access to 17,000+ market research reports.

ESMA updates its Q&As on MiFID II and MiFIR transparency (July 2020)

Saturday, July 11, 2020 - 12:02am

The European Securities and Markets Authority (ESMA), the EUs securities markets regulator, updated today its Q&As regarding transparency issues under the Markets in Financial Instruments Directive (MiFID II) and Regulation (MiFIR).

Key Points: 
  • The European Securities and Markets Authority (ESMA), the EUs securities markets regulator, updated today its Q&As regarding transparency issues under the Markets in Financial Instruments Directive (MiFID II) and Regulation (MiFIR).
  • The new Q&A document provides technical clarifications for the performance of the mandatory systematic internaliser (SI) test.
  • The purpose of this Q&A is to promote a common supervisory approach and practices in the EU on the application of MiFID II and MiFIR, in particular in the performance of the mandatory SI test.
  • ESMA will continue to develop Q&As in the coming months and will review and update them where required.

Oak Street Health Announces Filing of Registration Statement for Proposed Initial Public Offering

Friday, July 10, 2020 - 10:07pm

Oak Street Health, Inc. (Oak Street), a fast-growing network of value-based, primary care centers for adults on Medicare, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission for a proposed initial public offering of shares of its common stock.

Key Points: 
  • Oak Street Health, Inc. (Oak Street), a fast-growing network of value-based, primary care centers for adults on Medicare, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission for a proposed initial public offering of shares of its common stock.
  • The number of shares to be offered and the price range for the proposed offering have not yet been determined.
  • Oak Street intends to list its common stock on the New York Stock Exchange under the symbol OSH.
  • Founded in 2012, Oak Street Health is a fast-growing network of value-based, primary care centers for adults on Medicare.